Tenaya Therapeutics Dirección
Dirección controles de criterios 3/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Faraz Ali
Chief Executive Officer (CEO)
US$2.9m
Compensación total
| Porcentaje del salario del CEO | 20.5% |
| Permanencia del CEO | 6yrs |
| Participación del CEO | 0.02% |
| Permanencia media de la dirección | 5.5yrs |
| Promedio de permanencia en la Junta Directiva | 7.7yrs |
Actualizaciones recientes de la dirección
Recent updates
We're Keeping An Eye On Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Rate
Jun 04
Here's Why We're Watching Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Situation
Dec 20Is Tenaya Therapeutics (NASDAQ:TNYA) In A Good Position To Deliver On Growth Plans?
Aug 08Tenaya Therapeutics (NASDAQ:TNYA) Will Have To Spend Its Cash Wisely
Mar 07Can Tenaya Therapeutics (NASDAQ:TNYA) Afford To Invest In Growth?
Dec 06Tenaya Therapeutics gets U.S. FDA clearance for starting human trial of heart failure treatment
Sep 06Tenaya Therapeutics GAAP EPS of -$0.69 beats by $0.07
Aug 10Is Tenaya Therapeutics (NASDAQ:TNYA) In A Good Position To Deliver On Growth Plans?
Aug 08We're Hopeful That Tenaya Therapeutics (NASDAQ:TNYA) Will Use Its Cash Wisely
Mar 03Companies Like Tenaya Therapeutics (NASDAQ:TNYA) Are In A Position To Invest In Growth
Nov 01Tenaya Therapeutics: Treating Heart Disease Through 3 Product Platforms
Aug 06Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$125m |
| Dec 31 2023 | US$3m | US$594k | -US$124m |
| Sep 30 2023 | n/a | n/a | -US$128m |
| Jun 30 2023 | n/a | n/a | -US$129m |
| Mar 31 2023 | n/a | n/a | -US$124m |
| Dec 31 2022 | US$6m | US$571k | -US$124m |
| Sep 30 2022 | n/a | n/a | -US$116m |
| Jun 30 2022 | n/a | n/a | -US$104m |
| Mar 31 2022 | n/a | n/a | -US$91m |
| Dec 31 2021 | US$5m | US$494k | -US$73m |
| Sep 30 2021 | n/a | n/a | -US$57m |
| Jun 30 2021 | n/a | n/a | -US$49m |
| Mar 31 2021 | n/a | n/a | -US$42m |
| Dec 31 2020 | US$750k | US$425k | -US$38m |
Compensación vs. Mercado: La compensación total de Faraz($USD2.89M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD1.55M).
Compensación vs. Ingresos: La compensación de Faraz ha sido consistente con los resultados de la empresa en el último año.
CEO
Faraz Ali (51 yo)
6yrs
Permanencia
US$2,890,062
Compensación
Mr. Faraz Ali, M.B.A., serves as Chief Executive Officer since June 2018 & Director since September 2018 at Tenaya Therapeutics, Inc. and served as its Secretary since June 2018. Mr. Ali served as Chief Bu...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 6yrs | US$2.89m | 0.025% $ 60.3k | |
| Scientific Founder | no data | US$280.39k | 0.72% $ 1.8m | |
| Chief Financial & Business Officer | 3yrs | US$1.27m | 0.026% $ 64.7k | |
| Chief Medical Officer | 5.5yrs | US$1.38m | 0.032% $ 77.3k | |
| Scientific Founder & Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Scientific Founder | no data | sin datos | sin datos | |
| Scientific Founder | no data | sin datos | sin datos | |
| Scientific Founder | no data | sin datos | sin datos | |
| Scientific Founder | no data | sin datos | sin datos | |
| Chief Technology Officer | 2.3yrs | sin datos | sin datos | |
| Chief Scientific Officer | 6.8yrs | US$2.56m | 0.25% $ 609.5k | |
| Vice President of Investor Relationship & Corporate Communications | no data | sin datos | sin datos |
5.5yrs
Permanencia media
57.5yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de TNYA es experimentado (5.3 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 6yrs | US$2.89m | 0.025% $ 60.3k | |
| Scientific Founder | 7.7yrs | US$280.39k | 0.72% $ 1.8m | |
| Scientific Founder & Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Chairman of the Board | 7.8yrs | US$228.89k | sin datos | |
| Independent Director | 7.7yrs | US$198.89k | 0.032% $ 78.0k | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 4.3yrs | US$214.89k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 7.7yrs | US$207.39k | 0.038% $ 93.6k | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 4yrs | US$202.39k | 0.010% $ 25.4k |
7.7yrs
Permanencia media
61yo
Promedio de edad
Junta con experiencia: La junta directiva de TNYA se considera experimentada (7.5 años de antigüedad promedio).